Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07188415 · ClinicalTrials.gov registry record · NA
CMT Gait, Mobility, Balance - AOFAS Grant
A NA study of Charcot Marie Tooth Disease (CMT), sponsored by Bopha Chrea.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT07188415: Recruiting NA study of Charcot Marie Tooth Disease (CMT), sponsored by Bopha Chrea.
NCT07188415 is a NA study of Charcot Marie Tooth Disease (CMT) that is actively recruiting participants, run by Bopha Chrea. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07188415, a NA study of Charcot Marie Tooth Disease (CMT), is actively recruiting participants, sponsored by Bopha Chrea.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of the proposed research is to begin to better understand the potential benefits and limitations of ankle -foot orthosis (AFO) use in the context of mobility and balance during gait for individuals with Charcot-Marie-Tooth disease (CMT). These benefits will be studied in comparison to those offered by surgical correction. We will accomplish by having subjects undergo mobility and balance tests in our gait analysis lab.
Primary Outcome
This test of functional mobility requires rapid stepping and changes in direction, that are often limited by lower limb pathology.
Conditions Studied
Interventions
- DEVICE Ankle-foot Orthoses
Study Locations (1)
Iowa
- University of Iowa Medical Campus - North Liberty (MCNL) - North Liberty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-08-14 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT07188415 shows while recruiting
NCT07188415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Charcot Marie Tooth Disease (CMT) appearing as the primary indexed condition, and to 1 intervention - of which Ankle-foot Orthoses is the first listed.
NCT07188415 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT07188415 about?
NCT07188415 is a clinical study titled "CMT Gait, Mobility, Balance - AOFAS Grant". The overall objective of the proposed research is to begin to better understand the potential benefits and limitations of ankle -foot orthosis (AFO) use in the context of mobility and balance during gait for individuals with Charcot-Marie-Tooth disease (CMT). These benefits will be studied in compar...
What is the current status of trial NCT07188415?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-08-14. Estimated completion is 2027-01.
What conditions does trial NCT07188415 study?
This clinical trial studies the following conditions: Charcot Marie Tooth Disease (CMT).
What interventions are being tested in trial NCT07188415?
The interventions under investigation include: Ankle-foot Orthoses (DEVICE).
Who is sponsoring clinical trial NCT07188415?
This trial is sponsored by Bopha Chrea, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07188415 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Charcot Marie Tooth Disease (CMT)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07188415's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI